eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Reckitt Benckiser Healthcare (UK) Ltd

Freepost, RSBU-TEBT-GSTU, Reckitt Benckiser, Kingston Upon Thames, KT2 6LZ, UK
Telephone: +44 (0)500 455 456
WWW: http://www.reckittbenckiser.com
Medical Information Direct Line: +44 (0)500 455 456
Customer Care direct line: +44 (0)500 455 456

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 29/07/2010
SPC Karvol Decongestant Drops


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Karvol Decongestant Drops


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Ingredients

% W/V

Chlorobutanol Hemihydrate Ph Eur

0.50

Levomenthol Ph Eur

7.90

Pine Oil Sylvestris

2.00

Terpineol BP

14.80

Thymol Ph Eur

0.70

Pumilio Pine Oil

22.90


Go to top of the page
3. PHARMACEUTICAL FORM

Inhalation vapour, liquid


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the symptomatic relief of nasal congestion and colds in the head.


Go to top of the page
4.2 Posology and method of administration

For older children and adults:

For relief throughout the night: sprinkle 6 drops onto bedding or handkerchief nearby but avoiding direct skin contact.

Daytime: sprinkle 6 drops onto a tissue or into a pint of hot water and inhale the vapours freely.

For young children:

For daytime use and relief throughout the night: sprinkle 6 drops onto a handkerchief tied down securely in the vicinity but out of reach of the child..

Elderly: There is no need to modify the administration of this preparation for use by the elderly.

Children under 3 months: Not recommended for children under 3 months.


Go to top of the page
4.3 Contraindications

Children under 3 months of age


Go to top of the page
4.4 Special warnings and precautions for use

Avoid contact with the eyes and prolonged contact with the skin.

If symptoms persist consult your doctor.

Keep all medicines out of the reach of children.

For inhalation only.

Do not put drops directly in mouth or nose.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.


Go to top of the page
4.6 Pregnancy and lactation

The safety in pregnancy and lactation has not been established but it is not expected to constitute a hazard.


Go to top of the page
4.7 Effects on ability to drive and use machines

No adverse effects known.


Go to top of the page
4.8 Undesirable effects

None known.


Go to top of the page
4.9 Overdose

Symptoms of massive overdose by ingestion include nausea, vomiting, colic, headache, dizziness, a feeling of warmth, delirium, muscle twitching, epileptiform convulsions, depressed respiration, CNS depression and coma. Initial treatment consists of emptying the stomach by lavage and aspiration. Administer a saline laxative such as sodium sulphate and activated charcoal by mouth. Convulsions may be controlled with diazepam or thiopental sodium.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Chlorobutanol, levomenthol, pine oil, terpineol and thymol are volatile substances and are thought to produce an irritant effect on the respiratory tract, possibly via a nasal/pulmonary arc.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical safety data of relevance to the consumer.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Macrogol Stearate,

Cinnamon Oil,

Polysorbate 80,

Polyethylene Glycol 400,

Triacetin.


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

24 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

The liquid is contained in an amber glass bottle fitted with a combined all in one polyethylene/polypropylene dropper and a tamper evident child resistant polypropylene cap, or a non child resistant polypropylene cap. The bottle is presented in a cardboard carton.


Go to top of the page
6.6 Special precautions for disposal and other handling

Whilst applying drops ensure that the dropper bottle is held vertically.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Healthcare (UK) Limited

Dansom Lane

Hull

HU8 7DS

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00063/0406


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

08 May 1997


Go to top of the page
10. DATE OF REVISION OF THE TEXT

25 January 2008



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/23407/SPC/